Published in Acta Virol on September 01, 1970
Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology (1996) 1.30
Anti-interleukin-8 activity of tick salivary gland extracts. Parasite Immunol (2001) 0.92
Inhibition of the antiviral action of interferon by tick salivary gland extract. Parasite Immunol (2000) 0.88
Salivary gland extracts of partially fed Dermacentor reticulatus ticks decrease natural killer cell activity in vitro. Immunology (1994) 0.88
Heterogeneity in the effect of different ixodid tick species on human natural killer cell activity. Parasite Immunol (2002) 0.86
Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alpha. Acta Virol (1989) 0.86
An interferon like substance induced by mannans. Acta Virol (1967) 0.85
Tick salivary gland extracts promote virus growth in vitro. Parasitology (1998) 0.83
The effect of postfusion cell density on establishment of hybridomas. Folia Biol (Praha) (1988) 0.82
Double-stranded f 2 phage RNA as interferon inducer. Acta Virol (1971) 0.82
Enhancing effect of anti-endotoxic serum on interferon induction in mouse peritoneal cells by endotoxin. Acta Virol (1968) 0.81
Prevention of spontaneous autoimmunity to DNA in NZB/Swiss mice by treatment with natural double-stranded RNA. Immunology (1975) 0.81
Electrophoretic profiles and activities of human interferon in heterologous cells. Intervirology (1974) 0.81
Release of interferon by mouse peritoneal cells in vitro. The requirement of contact with endotoxin and the temperature dependence of release. Acta Virol (1969) 0.81
Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha. Immunology (1991) 0.81
A novel Notch3 Gly89Cys mutation in a Serbian CADASIL family. Acta Neurol Belg (2013) 0.79
Activation of NK cells in subjects exposed to mild hyper- or hypothermic load. J Interferon Res (1988) 0.79
Periodicity of interferon appearance in serum of patients with systemic lupus erythematosus. Arthritis Rheum (1984) 0.78
Interferon alpha2b is the predominant subvariant detected in human genomic DNAs. Acta Virol (1994) 0.78
Antiviral and cell-growth inhibitory activities of highly purified L-cell interferon. An analysis of quantitative disproportions. Acta Virol (1975) 0.78
The temperature requirement for interferon production in cells stimulated by Newcastle disease virus or microbial agents in vitro. Acta Virol (1967) 0.78
Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats. Am J Med Sci (2000) 0.78
Experimental pathogenesis of A-equi 1 influenza virus infection in horses. Acta Virol (1966) 0.78
Activation of the complement system by interferon inducers. Acta Virol (1972) 0.78
Preparation and characterization of hybridomas producing monoclonal antibodies against human alpha interferon. Acta Virol (1986) 0.78
The reticuloendothelial system and virus infection. II. Production of interferon- and antibody-like substances in mouse peritoneal cells infected with myxoviruses in vivo. Arch Gesamte Virusforsch (1965) 0.78
Interferon as therapeutic agent. Acta Virol (1983) 0.78
Promotion of vesicular stomatitis virus nucleocapsid protein production by arthopod saliva. Acta Virol (1999) 0.78
Human acid- and thermolabile alpha-interferon-like substance: selective reactivity with a monoclonal antibody. Antiviral Res (1989) 0.78
Current view on the perspectives of interferon therapy. Acta Virol (1986) 0.77
The cell-growth inhibitory effect of interferon. Studies of a resistant cell-subline. Neoplasma (1977) 0.77
Cross-species antiviral and antiproliferative activity of human interferon-omega. J Interferon Res (1994) 0.77
Distribution of antiviral and cell-inhibitory activity in interferon preparations. Acta Virol (1972) 0.77
Are the acid-labile interferon alpha and interferon omega-1 identical? Virology (1991) 0.77
Therapeutic use of double-stranded RNAs in man. Tex Rep Biol Med (1983) 0.77
Comparison of manganese superoxide dismutase precursor induction ability in human hepatoma cells with or without hepatitis B virus DNA insertion. Acta Virol (2000) 0.77
Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodies. Acta Virol (1976) 0.77
Stimulation of interferon production by mannans. Proc Soc Exp Biol Med (1970) 0.76
Immunodominant structures in the aminoterminal portion of human interferon alpha 1. Mol Immunol (1992) 0.76
Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2. Immunol Lett (1993) 0.76
Interferon alpha-induced modulation of leukocyte cell surface antigens: immunocytofluorometric study with human leukaemia/lymphoma cell lines. Acta Virol (1991) 0.76
[N[2-hydroxyethyl] palmitamide repeated administration effect on interferon production in mouse organism after phage double-stranded ribonucleic acid [ds-RNA] application (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1978) 0.76
Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors. Acta Virol (1989) 0.76
Effect of impulsin treatment of interferon production and antiviral resistance of mice. Arch Immunol Ther Exp (Warsz) (1977) 0.76
Blood-brain barrier permeability changes during acute allergic encephalomyelitis induced in the guinea pig. Metab Brain Dis (1989) 0.76
Vesicular stomatitis virus nucleocapsid protein production in cells treated with selected fast protein liquid chromatography fractions of tick salivary gland extracts. Acta Virol (2002) 0.75
Interactions between viral infection and immune mechanisms. Comp Immunol Microbiol Infect Dis (1980) 0.75
Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women. Arch Immunol Ther Exp (Warsz) (1995) 0.75
Use of bacteriophage nucleic acid inducers of interferon in man. Tex Rep Biol Med (1977) 0.75
The effect of native and sonicated double-stranded polyribonucleotides on the course of spontaneous autoimmune disease in NZB and NZB/Swiss F1 mice. Acta Virol (1979) 0.75
Antiviral and cell-growth inhibitory effect of interferon. Biomedicine (1973) 0.75
Quantitative immunoelectrophoresis of human interferon. A new approach to characterization of interferon preparations. Acta Virol (1978) 0.75
Interferon research and our possibilities. Some concluding thoughts. Arch Immunol Ther Exp (Warsz) (1977) 0.75
Preparation of highly sensitive mouse hybrid cells for interferon assays. J Immunol Methods (1989) 0.75
The cell growth inhibitory and antiviral effects of interferon in cloned transformed mouse cells. Ann N Y Acad Sci (1980) 0.75
[Double-fiber ribonucleic acid in the treatment of viral dermatoses]. Cesk Dermatol (1973) 0.75
Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levels. Acta Virol (1975) 0.75
Murine monoclonal antibodies against human fibroblast (beta) interferon. Correlation of the neutralization of antiviral and antiproliferative activities. Acta Virol (1989) 0.75
Twenty years after discovery of interferon: the progress and the persistent problems. Acta Biol Med Ger (1979) 0.75
Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35. J Interferon Res (1991) 0.75
Partial heterologous tolerance to interferon production in mice infected with B. pertussis. Acta Virol (1966) 0.75
[Peritoneal macrophages and interferon formation (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1974) 0.75
Decrease of sensitivity to cell-growth inhibitory effect of interferon in human embryo cells after infection with SV40. Acta Virol (1979) 0.75
Some biological activities of rabbit anti-interferon serum. Acta Virol (1976) 0.75
Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice. Acta Virol (1980) 0.75
Modification of the antigenic structure of human interferon alpha-2 by PH 2 treatment: a further support for the antigenic relationship between alpha and beta interferons. Acta Virol (1990) 0.75
The effect of interferon induction on complement level in rat. Acta Biol Med Ger (1979) 0.75
Some biological activites of rabbit anti-interferon serum. Arch Immunol Ther Exp (Warsz) (1977) 0.75
Antigenic link between human interferons-alpha and -beta: the common epitope 1. J Interferon Res (1990) 0.75
Effect of different polyribonucleotides on the induction of antibodies to DNA and RNA and serum complement level in mice. Acta Biol Med Ger (1979) 0.75
Long-term culture of guinea pig tongue cells: a suitable interferon system. Acta Virol (1979) 0.75
Production of antiviral and migration inhibitory activities in the peritoneum of mice after inoculation with allogenic Ehrlich ascites tumor cells. Acta Biol Med Ger (1979) 0.75
Antiviral and anticellular effects of interferon on the mouse embryonic cells transformed by viruses and/or chemical carcinogen. Acta Biol Med Ger (1979) 0.75
Production of interferon and other lymphokines during murine tumour growth. I. Lymphokines in cell--free fluid of rat Zajdela ascites hepatoma. Acta Virol (1980) 0.75
Some properties of interferon released by mouse peritoneal leukocytes stimulated with endotoxin, mannan and Newcastle disease virus in vitro. Acta Virol (1970) 0.75
Patterns of interferon induction in leuckocytes. Acta Microbiol Pol A (1973) 0.75
Production of human leukocyte interferon for clinical use under immunoelectrophoretic control. Acta Biol Med Ger (1979) 0.75
Monoclonal antibodies neutralizing the antiviral and the antiproliferative activities of human interferon gamma. Acta Virol (1988) 0.75
Levels of complement during interferon induction. Arch Immunol Ther Exp (Warsz) (1977) 0.75
Relation of incubation temperature to interferon production in mouse peritoneal cells infected with Newcastle disease virus. Acta Virol (1969) 0.75
Release of an interferon-like virus inhibitor during contact of mouse leukocytes with target cells. Acta Virol (1970) 0.75
[Double stranded RNA and a nonspecific stimulator of the organism's defense mechanism]. Bratisl Lek Listy (1978) 0.75